Statements about H.R.2855: To deem the application submitted by Jaci Hermstad to the Food and Drug Administration for compassionate use of the gene therapy antisense oligonucleotides to be approved.
One member of Congress have made three statements about this bill.
Date | Member | Party | State / District | Title |
---|---|---|---|---|
Feb. 4, 2020 | Steve King | R | IA-4 | Kings Special Guest for President Trumps State of the Union Address: Jason Harrington, President and CEO of Lakes Regional Healthcare |
June 25, 2019 | Steve King | R | IA-4 | King Honors Jaci Hermstad on the House Floor |
May 24, 2019 | Steve King | R | IA-4 | King Welcomes FDAs Decision to Expedite Jaci Hermstads Treatment |